Melinta Therapeutics (NASDAQ: MLNT), a commercial-stage pharmaceutical Company, engaged in developing therapeutic options for treatment of bacterial infectious diseases, filed for Chapter 11 bankruptcy in January 2020. The Company had concerns about its financial prospects and warned the investors that it would be difficult to...
Inhibitor Therapeutics (OTCQB: INTI), a Biopharmaceutical Company focussed on addressing the unmet medical needs in the field of cancerous and non-cancerous proliferation disorders, announced the receipt of an Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for traconazole, intended for...
A Group of lawmakers from the state of Washington put forward a proposal namely House Bill 2546, which calls for limiting THC levels to no more than 10%, owing to concerns about a possible link between Cannabis and psychosis, prompting them to seek the reduction...
Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical Company engaged in developing candidates for oncology, auto-immune and chronic pain, has announced the withdrawal of its application for oxycodegol (formerly NKTR-181), as it received adverse advisory committee decision from both Anesthetic and Analgesic Drug Products Advisory Committee, and...
OrganiGram Holdings (NASDAQ: OGI), a prominent player in the Canadian Cannabis sector, surprised analysts and the cannabis industry alike with the announcement of better- than-expected fiscal first-quarter revenue, providing an impetus to an otherwise lacklustre year. The Company reported a 102.2 percent increase in revenues...
Catabasis Pharmaceuticals (NASDAQ: CATB), a clinical-stage Company leveraging its proprietary SMART (Safely Metabolized and Rationally Targeted) Linker drug discovery platform to treat multiple biological targets announced a partnership with Duchenne UK, a London-based charity that funds treatments for Duchenne Muscular Dystrophy (DMD). The partnership will...
Accuray Inc (NASDAQ: ARAY), a Company developing robotic stereotactic radiosurgery and stereotactic body radiation therapy system, specifically the CyberKnife System, announced the data from a prospective study which demonstrates the efficacy and safety of its stereotactic body radiation therapy (SBRT), administered using the CyberKnife system....
Huntington’s disease is a progressive degeneration of the neurons in the brain resulting in loss of cognition, motor ability, uncontrolled movements and emotional distress. The disease can be categorized into adult onset, which manifests in the form of depression, irritability, lack of coordination and poor...
GreenLane Holdings Inc (NASDAQ: GNLN), a Company dealing in wholesale and retail distribution of consumption accessories and vaporization products, announced a comprehensive distribution agreement with Advanced Vapor Devices (AVD), a manufacturer of vaporizer cartridges and batteries. The agreement will cover the entire range of AVD...
ChromaDex (NASDAQ: CDXC), a nutraceutical Company focussed on improving the way people age, announced the launch of a “first-of-its-kind” Phase 1 clinical study to test the safety, efficacy and potential of branded nicotinamide riboside (NR), Niagen, in improving the effects of exercise therapy in older...
